Maximize Control

  • Clearly understand the full impact of medication delivery workflow across departments, facilities and settings
  • Have visibility into inventory and processes across all points of medication delivery for better control and actionable decision-making
  • Take cost out of the medication delivery process without compromising quality of care

Learn More

Anticipate Change

  • Create a long-term strategy that anticipates evolving demands and requirements
  • Embrace innovative technologies that offer scalable, interoperable solutions
  • Build a culture of adaptability and accountability across people and processes

Learn More

Increase Time for Care

  • Improve medication supply chain processes to give pharmacists more time to focus on clinical care
  • Enable critical nursing resources to practice top-of-license activities that will impact outcomes
  • Realize savings through more efficient medication delivery to fund clinical initiatives

Learn More

How can data change your pharmacy?

Aesynt's newly launched Registry for Intravenous Technology in Pharmacy (REINVENT™), is a global, multi-site registry of compounded sterile preparation (CSP) data designed to help you analyze current industry trends, benchmark measures for process improvement and continue to innovate within the IV compounding space.
Learn more.

News

July 17, 2015
Becker’s Hospital Review One critical but often overlooked area for taking cost out is the pharmacy supply chain and medication inventory processes
July 15, 2015
Pharmacy Purchasing... [+]
June 22, 2015
Executive Insight Aesynt’s Curtis McEntire discusses the importance of medication visibility across the enterprise to improve cost, quality and... [+]
June 16, 2015
Aesynt Achieves Significant Growth as Private Company Business plans significant manufacturing expansion in Pittsburgh region CRANBERRY... [+]

Upcoming Events

August 9, 2015 to August 11, 2015
AHRMM 2015, Indianapolis, IN "How Two Health Systems Are Unlocking Savings in their Pharmacy Supply Chains," presented by Chris Parrish, VP of Lab,... [+]